1. Home
  2. IRIX vs ENLV Comparison

IRIX vs ENLV Comparison

Compare IRIX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • ENLV
  • Stock Information
  • Founded
  • IRIX 1989
  • ENLV 2005
  • Country
  • IRIX United States
  • ENLV Israel
  • Employees
  • IRIX N/A
  • ENLV N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • ENLV Health Care
  • Exchange
  • IRIX Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • IRIX 22.4M
  • ENLV 25.5M
  • IPO Year
  • IRIX 1996
  • ENLV 1995
  • Fundamental
  • Price
  • IRIX $1.29
  • ENLV $1.09
  • Analyst Decision
  • IRIX
  • ENLV Strong Buy
  • Analyst Count
  • IRIX 0
  • ENLV 2
  • Target Price
  • IRIX N/A
  • ENLV $10.00
  • AVG Volume (30 Days)
  • IRIX 86.5K
  • ENLV 494.4K
  • Earning Date
  • IRIX 11-11-2025
  • ENLV 08-29-2025
  • Dividend Yield
  • IRIX N/A
  • ENLV N/A
  • EPS Growth
  • IRIX N/A
  • ENLV N/A
  • EPS
  • IRIX N/A
  • ENLV N/A
  • Revenue
  • IRIX $49,744,000.00
  • ENLV N/A
  • Revenue This Year
  • IRIX $9.61
  • ENLV N/A
  • Revenue Next Year
  • IRIX N/A
  • ENLV N/A
  • P/E Ratio
  • IRIX N/A
  • ENLV N/A
  • Revenue Growth
  • IRIX 0.09
  • ENLV N/A
  • 52 Week Low
  • IRIX $0.78
  • ENLV $0.81
  • 52 Week High
  • IRIX $2.04
  • ENLV $2.10
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 50.65
  • ENLV 44.54
  • Support Level
  • IRIX $1.31
  • ENLV $1.00
  • Resistance Level
  • IRIX $1.47
  • ENLV $1.08
  • Average True Range (ATR)
  • IRIX 0.07
  • ENLV 0.04
  • MACD
  • IRIX -0.01
  • ENLV 0.01
  • Stochastic Oscillator
  • IRIX 16.25
  • ENLV 80.00

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: